AI-powered pharmacovigilance: From reactive reporting to predictive risk
Pharmacovigilance (PV) is entering a new era that will transform safety conduct from today’s reactive reporting to predictive risk assessment. This transformation will be fueled by unprecedented volumes of real-world health data and operationalized by artificial intelligence (AI) and predictive analytics. In this paper, we discuss current, near-term and future AI applications, with examples of Parexel’s emerging AI solutions to advance efficiencies and insights in pharmacovigilance practice.
Related Insights
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Article
Delivering AI-managed clinical research data: Parexel’s end-to-end automation strategy
Mar 11, 2025
Blog
AI Milestones: AI-enabled EKG reads and alerts save lives: human-AI collaboration in practice
Jun 6, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Related Insights
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Article
Delivering AI-managed clinical research data: Parexel’s end-to-end automation strategy
Mar 11, 2025
Blog
AI Milestones: AI-enabled EKG reads and alerts save lives: human-AI collaboration in practice
Jun 6, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022